Literature DB >> 24080583

Hypertension: Do calcium-channel blockers increase breast cancer risk?

Ange Wang1, JoAnn E Manson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24080583     DOI： 10.1038/nrcardio.2013.155

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.

Authors:  Sripal Bangalore; Sunil Kumar; Sverre E Kjeldsen; Harikrishna Makani; Ehud Grossman; Jørn Wetterslev; Ajay K Gupta; Peter S Sever; Christian Gluud; Franz H Messerli
Journal:  Lancet Oncol       Date:  2010-11-29       Impact factor: 41.316

2.  A cohort study of antihypertensive medication use and breast cancer among Danish women.

Authors:  Jon P Fryzek; Aslak H Poulsen; Loren Lipworth; Lars Pedersen; Mette Nørgaard; Joseph K McLaughlin; Søren Friis
Journal:  Breast Cancer Res Treat       Date:  2006-05-03       Impact factor: 4.872

3.  Use of calcium channel blockers and breast carcinoma risk in postmenopausal women.

Authors:  A L Fitzpatrick; J R Daling; C D Furberg; R A Kronmal; J L Weissfeld
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

4.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

Review 5.  Calcium channel blockers, apoptosis and cancer: is there a biologic relationship?

Authors:  R P Mason
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

6.  Calcium-channel blockade and incidence of cancer in aged populations.

Authors:  M Pahor; J M Guralnik; L Ferrucci; M C Corti; M E Salive; J R Cerhan; R B Wallace; R J Havlik
Journal:  Lancet       Date:  1996-08-24       Impact factor: 79.321

7.  Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex.

Authors:  Suzanne Oparil; Barry R Davis; William C Cushman; Charles E Ford; Curt D Furberg; Gabriel B Habib; L Julian Haywood; Karen Margolis; Jeffrey L Probstfield; Paul K Whelton; Jackson T Wright
Journal:  Hypertension       Date:  2013-03-25       Impact factor: 10.190

8.  Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study.

Authors:  K B Michels; B A Rosner; A M Walker; M J Stampfer; J E Manson; G A Colditz; C H Hennekens; W C Willett
Journal:  Cancer       Date:  1998-11-01       Impact factor: 6.860

9.  Use of antihypertensive medications and breast cancer risk among women aged 55 to 74 years.

Authors:  Christopher I Li; Janet R Daling; Mei-Tzu C Tang; Kara L Haugen; Peggy L Porter; Kathleen E Malone
Journal:  JAMA Intern Med       Date:  2013-09-23       Impact factor: 21.873

10.  Beta blockers and angiotensin-converting enzyme inhibitors' purported benefit on breast cancer survival may be explained by aspirin use.

Authors:  Michelle D Holmes; Susan E Hankinson; Diane Feskanich; Wendy Y Chen
Journal:  Breast Cancer Res Treat       Date:  2013-05-07       Impact factor: 4.872
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.